FDA Inspection 1239875 — Xiamen LP Pharmaceutical Co., Ltd.
The FDA completed an inspection of Xiamen LP Pharmaceutical Co., Ltd. on Apr 19, 2024 in Xia Men. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 19, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xia Men (China)